IL144916A0 - Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone - Google Patents

Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone

Info

Publication number
IL144916A0
IL144916A0 IL14491600A IL14491600A IL144916A0 IL 144916 A0 IL144916 A0 IL 144916A0 IL 14491600 A IL14491600 A IL 14491600A IL 14491600 A IL14491600 A IL 14491600A IL 144916 A0 IL144916 A0 IL 144916A0
Authority
IL
Israel
Prior art keywords
bromoepiandrosterone
hemihydrate
immunomodulatory
steroids
alpha
Prior art date
Application number
IL14491600A
Other languages
English (en)
Original Assignee
Holis Eden Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holis Eden Pharmaceuticals Inc filed Critical Holis Eden Pharmaceuticals Inc
Publication of IL144916A0 publication Critical patent/IL144916A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14491600A 1999-03-23 2000-03-23 Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone IL144916A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12605699P 1999-03-23 1999-03-23
US14002899P 1999-06-16 1999-06-16
US41490599A 1999-10-08 1999-10-08
US16404899P 1999-11-08 1999-11-08
PCT/US2000/007883 WO2000056757A1 (en) 1999-03-23 2000-03-23 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone

Publications (1)

Publication Number Publication Date
IL144916A0 true IL144916A0 (en) 2002-06-30

Family

ID=27494614

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14491600A IL144916A0 (en) 1999-03-23 2000-03-23 Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone

Country Status (22)

Country Link
EP (1) EP1163256B1 (cs)
JP (1) JP2002540119A (cs)
KR (2) KR100717897B1 (cs)
CN (1) CN1243767C (cs)
AP (1) AP2001002285A0 (cs)
AT (1) ATE259825T1 (cs)
AU (1) AU781997B2 (cs)
BR (1) BR0009476A (cs)
CA (1) CA2365081A1 (cs)
CZ (1) CZ20013420A3 (cs)
DE (1) DE60008353T2 (cs)
DK (1) DK1163256T3 (cs)
ES (1) ES2215631T3 (cs)
HK (1) HK1046002B (cs)
HU (1) HUP0203429A3 (cs)
IL (1) IL144916A0 (cs)
NO (2) NO320801B1 (cs)
NZ (1) NZ513803A (cs)
OA (1) OA11850A (cs)
PT (1) PT1163256E (cs)
RU (2) RU2295534C2 (cs)
WO (1) WO2000056757A1 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070129282A1 (en) 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
DK1955700T3 (da) 1999-09-30 2011-05-23 Harbor Biosciences Inc Terapeutisk behandling af androgenreceptor-betingede lidelser
AU2001241779A1 (en) 2000-02-25 2001-09-03 Hollis-Eden Pharmaceuticals, Inc. Method of treatment of prostate cancer
WO2002069977A1 (en) * 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Use of certain steroids for treatment of blood cell deficiencies
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin
KR20050057086A (ko) 2002-08-28 2005-06-16 홀리스-에덴 파마슈티칼즈, 인코포레이티드 치료적 처치 방법
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR101293350B1 (ko) * 2003-12-26 2013-08-05 다이쇼 세이야꾸 가부시끼가이샤 호중구증다 억제제
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
CN104072564B (zh) * 2013-03-28 2016-08-17 广州市赛普特医药科技股份有限公司 2β,3α,5α-三羟基-雄甾-6-酮及其制备方法与用途
CN106565654B (zh) * 2016-10-14 2018-08-31 云南中烟工业有限责任公司 一种从白云参中提取的新型黄酮类化合物、其制备方法及其用途
US10836788B2 (en) 2019-02-05 2020-11-17 SD Chem, Inc. Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
CN114907333B (zh) * 2022-05-11 2023-07-04 中国人民解放军军事科学院军事医学研究院 环丙甲酰胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH197784A (de) * 1934-05-25 1938-05-15 Schering Kahlbaum Ag Verfahren zu Darstellung von D5,6-trans-Androstendiol-3,17.
IE72193B1 (en) * 1983-08-02 1997-03-26 Res Corp Technologies Inc Steroids useful as anti-cancer anti-obesity anti-hyperglycemic anti-autoimmune and anti-hypercholesterolemic agents
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
JPH0289327A (ja) * 1988-09-27 1990-03-29 Matsushita Electron Corp 銀ペースト塗布装置
US5837269A (en) * 1989-09-25 1998-11-17 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates

Also Published As

Publication number Publication date
RU2001128881A (ru) 2003-09-27
NO20056167L (no) 2001-11-21
RU2006133273A (ru) 2008-03-27
CZ20013420A3 (cs) 2002-04-17
ES2215631T3 (es) 2004-10-16
CN1243767C (zh) 2006-03-01
RU2417792C2 (ru) 2011-05-10
WO2000056757A1 (en) 2000-09-28
EP1163256B1 (en) 2004-02-18
KR20020003217A (ko) 2002-01-10
HK1046002B (zh) 2006-10-20
CN1355809A (zh) 2002-06-26
BR0009476A (pt) 2002-02-19
DK1163256T3 (da) 2004-06-28
JP2002540119A (ja) 2002-11-26
HK1046002A1 (en) 2002-12-20
NO20014588D0 (no) 2001-09-21
HUP0203429A3 (en) 2004-07-28
DE60008353D1 (de) 2004-03-25
AU781997B2 (en) 2005-06-23
PT1163256E (pt) 2004-07-30
NO20014588L (no) 2001-11-21
NZ513803A (en) 2004-06-25
RU2295534C2 (ru) 2007-03-20
AU3919000A (en) 2000-10-09
KR20070007394A (ko) 2007-01-15
AP2001002285A0 (en) 2001-12-31
CA2365081A1 (en) 2000-09-28
EP1163256A1 (en) 2001-12-19
ATE259825T1 (de) 2004-03-15
OA11850A (en) 2006-03-06
KR100717897B1 (ko) 2007-05-14
HUP0203429A2 (hu) 2003-01-28
NO320801B1 (no) 2006-01-30
DE60008353T2 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
IL146223A0 (en) Steroid derivatives
HUP0400646A3 (en) Steroid hormone-compositions and processes for their preparation
HRP20020944A2 (en) 3-nitrogen-6,7-dioxygen steroids and uses related thereto
GB9909886D0 (en) Auxiliary erotic implement
EP1115203A4 (en) OUTPUT CONTROL UNIT
GB2355250B (en) Parallel-gripping chuck
IL144916A0 (en) Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone
IL144455A0 (en) 16-hydroxyestratrienes as selective estrogens
IL149715A0 (en) MICROBIAL 9α-HYDROXYLATION OF STEROIDS
GB9922830D0 (en) Processes
GB9930390D0 (en) Releasable fasteners
GB2352661B (en) Chuck
EP1150628A4 (en) CONDOM
EP1238799A4 (en) PLASTIFIER MACHINE
GB2350989B (en) Background-noise reduction
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
GB0011191D0 (en) Chuck
AU5326400A (en) Sulfated sterol derivatives and processes for preparing the same
GB0028576D0 (en) Cabin
GB0017933D0 (en) Building component
AU2003600A (en) External steroid preparation
GB9921851D0 (en) Structural elements
GB9926508D0 (en) Improved fittings
EG22401A (en) Set 3c1-strong
GB2368546B (en) Chuck

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees